Article Text

PDF
Coronary artery disease
Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion
  1. S-A Chang1,2,
  2. H-J Kang1,2,
  3. H-Y Lee1,2,
  4. K-H Kim1,
  5. J Hur1,
  6. K-S Han3,
  7. Y-B Park2,4,
  8. H-S Kim1,2,4
  1. 1
    National Research Laboratory for Cardiovascular Stem Cell, Seoul National University Hospital, Seoul, Republic of Korea
  2. 2
    Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea
  3. 3
    Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea
  4. 4
    Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Republic of Korea
  1. Professor Hyo-Soo Kim, Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong Chongno-gu, Seoul, 110-744 Korea; hyosoo{at}snu.ac.kr

Abstract

Background/aims: Peripheral blood stem cells (PBSC) are one of the most promising stem cell sources for treatment of ischaemic heart disease. However, the experience of mobilisation and collection of PBSC using granulocyte-colony stimulating factor (G-CSF) in patients with myocardial infarction (MI) is still limited. We report our experiences with the feasibility and safety of collection of mobilised PBSC with G-CSF in MI patients, and the influence of acute ischaemia on efficacy of PBSC collection.

Methods: 74 patients with acute or old myocardial infarction (AMI vs OMI, n = 46 and n = 28) underwent PBSC collection after administration of G-CSF twice a day at a dose of 5 μg/kg for 3 days. Flow cytometric analysis of cell surface markers was performed.

Results: No evidence of inflammation or ischaemia was observed during G-CSF mobilisation and PBSC collection. The yield of CD34+ cells was 12.9 (SD 15.92) ×109/l (5.04% (5.30%) of total cells) with a product volume of 37.9 (8.4) ml after 5650 (987) ml of blood were processed during PBSC collection. Stem cell mobilisation and collection by G-CSF is more efficient in AMI than in OMI, and proportions of cells positive for VE-cadherin or KDR/CD34 are significantly greater in AMI than in OMI (p<0.01).

Conclusion: We could obtain sufficient numbers of PBSC for intracoronary infusion with the G-CSF-based mobilisation strategy without complications even in patients with MI. PBSC collection after mobilisation with G-CSF is a safe and feasible method of stem cell collection for therapeutic purpose in patients with MI.

Statistics from Altmetric.com

Footnotes

  • See Editorial, p 1301

  • ▸ Additional data are published online only at http://heart.bmj.com/content/vol95/issue16

  • S-AC and H-JK equally contributed to this work.

  • Funding: This study was supported by a grant from Stem Cell Research Center (SC4210 to YBP), and the Innovative Research Institute for Cell Therapy (to HSK).

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles